This pipeline computes the correlation between significant copy number variation (cnv focal) genes and selected clinical features.
Testing the association between copy number variation 39 focal events and 13 clinical features across 859 patients, 253 significant findings detected with Q value < 0.25.
-
amp_1q32.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'HISTOLOGICAL_TYPE', and 'YEAR_OF_TOBACCO_SMOKING_ONSET'.
-
amp_2q32.1 cnv correlated to 'PATHOLOGY_N_STAGE' and 'HISTOLOGICAL_TYPE'.
-
amp_3q26.32 cnv correlated to 'YEARS_TO_BIRTH', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'KARNOFSKY_PERFORMANCE_SCORE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
amp_5q35.1 cnv correlated to 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
amp_7q31.2 cnv correlated to 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_M_STAGE', 'GENDER', 'HISTOLOGICAL_TYPE', and 'YEAR_OF_TOBACCO_SMOKING_ONSET'.
-
amp_8q24.22 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'HISTOLOGICAL_TYPE', 'NUMBER_PACK_YEARS_SMOKED', and 'RACE'.
-
amp_10p14 cnv correlated to 'PATHOLOGY_T_STAGE' and 'PATHOLOGY_N_STAGE'.
-
amp_17q25.2 cnv correlated to 'YEARS_TO_BIRTH', 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'GENDER', 'HISTOLOGICAL_TYPE', 'YEAR_OF_TOBACCO_SMOKING_ONSET', and 'RACE'.
-
amp_19p13.2 cnv correlated to 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_M_STAGE', and 'HISTOLOGICAL_TYPE'.
-
amp_xp22.2 cnv correlated to 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', 'GENDER', 'KARNOFSKY_PERFORMANCE_SCORE', 'HISTOLOGICAL_TYPE', and 'YEAR_OF_TOBACCO_SMOKING_ONSET'.
-
amp_xp11.4 cnv correlated to 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', 'GENDER', 'KARNOFSKY_PERFORMANCE_SCORE', 'HISTOLOGICAL_TYPE', and 'YEAR_OF_TOBACCO_SMOKING_ONSET'.
-
amp_xq11.2 cnv correlated to 'Time to Death', 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', 'GENDER', 'KARNOFSKY_PERFORMANCE_SCORE', 'HISTOLOGICAL_TYPE', and 'YEAR_OF_TOBACCO_SMOKING_ONSET'.
-
amp_xq28 cnv correlated to 'Time to Death', 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', 'GENDER', 'KARNOFSKY_PERFORMANCE_SCORE', and 'HISTOLOGICAL_TYPE'.
-
del_1p36.31 cnv correlated to 'YEARS_TO_BIRTH', 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'KARNOFSKY_PERFORMANCE_SCORE', and 'HISTOLOGICAL_TYPE'.
-
del_1p31.1 cnv correlated to 'YEARS_TO_BIRTH', 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'HISTOLOGICAL_TYPE', and 'ETHNICITY'.
-
del_1q43 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', and 'HISTOLOGICAL_TYPE'.
-
del_2q37.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_M_STAGE', and 'HISTOLOGICAL_TYPE'.
-
del_3p26.3 cnv correlated to 'Time to Death', 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'GENDER', 'HISTOLOGICAL_TYPE', 'YEAR_OF_TOBACCO_SMOKING_ONSET', and 'RACE'.
-
del_3p21.2 cnv correlated to 'Time to Death', 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'KARNOFSKY_PERFORMANCE_SCORE', 'HISTOLOGICAL_TYPE', 'YEAR_OF_TOBACCO_SMOKING_ONSET', and 'RACE'.
-
del_3p14.1 cnv correlated to 'Time to Death', 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', 'HISTOLOGICAL_TYPE', 'YEAR_OF_TOBACCO_SMOKING_ONSET', and 'RACE'.
-
del_3p12.2 cnv correlated to 'Time to Death', 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', 'GENDER', 'HISTOLOGICAL_TYPE', 'YEAR_OF_TOBACCO_SMOKING_ONSET', and 'RACE'.
-
del_4q34.3 cnv correlated to 'Time to Death', 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
del_5p15.33 cnv correlated to 'YEARS_TO_BIRTH', 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', and 'HISTOLOGICAL_TYPE'.
-
del_6q22.31 cnv correlated to 'YEARS_TO_BIRTH', 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'KARNOFSKY_PERFORMANCE_SCORE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
del_6q26 cnv correlated to 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'KARNOFSKY_PERFORMANCE_SCORE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
del_6q26 cnv correlated to 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'KARNOFSKY_PERFORMANCE_SCORE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
del_8p23.2 cnv correlated to 'Time to Death', 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_M_STAGE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
del_9p23 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'KARNOFSKY_PERFORMANCE_SCORE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
del_9p21.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'KARNOFSKY_PERFORMANCE_SCORE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
del_10q23.31 cnv correlated to 'YEARS_TO_BIRTH', 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
del_11q21 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'KARNOFSKY_PERFORMANCE_SCORE', and 'HISTOLOGICAL_TYPE'.
-
del_11q23.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'KARNOFSKY_PERFORMANCE_SCORE', and 'HISTOLOGICAL_TYPE'.
-
del_13q12.13 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'GENDER', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
del_13q14.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'GENDER', 'HISTOLOGICAL_TYPE', and 'RACE'.
-
del_14q31.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'KARNOFSKY_PERFORMANCE_SCORE', 'HISTOLOGICAL_TYPE', 'YEAR_OF_TOBACCO_SMOKING_ONSET', and 'RACE'.
-
del_16q23.3 cnv correlated to 'Time to Death', 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', and 'PATHOLOGY_N_STAGE'.
-
del_18q22.2 cnv correlated to 'Time to Death', 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'YEAR_OF_TOBACCO_SMOKING_ONSET', 'RACE', and 'ETHNICITY'.
-
del_19p13.3 cnv correlated to 'Time to Death', 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', 'KARNOFSKY_PERFORMANCE_SCORE', and 'HISTOLOGICAL_TYPE'.
-
del_xp22.2 cnv correlated to 'YEARS_TO_BIRTH', 'NEOPLASM_DISEASESTAGE', 'PATHOLOGY_T_STAGE', 'PATHOLOGY_N_STAGE', and 'HISTOLOGICAL_TYPE'.
Clinical Features |
Time to Death |
YEARS TO BIRTH |
NEOPLASM DISEASESTAGE |
PATHOLOGY T STAGE |
PATHOLOGY N STAGE |
PATHOLOGY M STAGE |
GENDER |
KARNOFSKY PERFORMANCE SCORE |
HISTOLOGICAL TYPE |
NUMBER PACK YEARS SMOKED |
YEAR OF TOBACCO SMOKING ONSET |
RACE | ETHNICITY | ||
nCNV (%) | nWild-Type | logrank test | Wilcoxon-test | Fisher's exact test | Fisher's exact test | Fisher's exact test | Fisher's exact test | Fisher's exact test | Wilcoxon-test | Fisher's exact test | Wilcoxon-test | Wilcoxon-test | Fisher's exact test | Fisher's exact test | |
del 14q31 1 | 274 (32%) | 585 |
8.67e-09 (8.79e-07) |
0.0799 (0.178) |
1e-05 (7.57e-05) |
1e-05 (7.57e-05) |
0.00205 (0.00829) |
4.84e-05 (0.000332) |
0.699 (0.819) |
0.0447 (0.111) |
1e-05 (7.57e-05) |
0.163 (0.305) |
0.00272 (0.0106) |
0.011 (0.0346) |
1 (1.00) |
amp 8q24 22 | 121 (14%) | 738 |
0.00646 (0.0217) |
0.0485 (0.119) |
1e-05 (7.57e-05) |
1e-05 (7.57e-05) |
0.0615 (0.147) |
0.00979 (0.0312) |
0.533 (0.664) |
0.86 (0.932) |
0.00092 (0.0042) |
0.118 (0.237) |
0.149 (0.287) |
0.00454 (0.0162) |
1 (1.00) |
del 3p21 2 | 499 (58%) | 360 |
7.97e-06 (7.57e-05) |
0.683 (0.803) |
1e-05 (7.57e-05) |
1e-05 (7.57e-05) |
0.0986 (0.208) |
0.0049 (0.017) |
0.143 (0.277) |
0.0596 (0.143) |
1e-05 (7.57e-05) |
0.194 (0.342) |
0.0343 (0.0893) |
1e-05 (7.57e-05) |
0.873 (0.936) |
del 9p23 | 196 (23%) | 663 |
2.91e-11 (4.92e-09) |
0.0247 (0.068) |
1e-05 (7.57e-05) |
1e-05 (7.57e-05) |
0.00724 (0.0241) |
0.000223 (0.00121) |
0.301 (0.453) |
0.0204 (0.0586) |
1e-05 (7.57e-05) |
0.932 (0.966) |
0.525 (0.656) |
0.0126 (0.0389) |
0.704 (0.82) |
del 9p21 3 | 207 (24%) | 652 |
1.12e-14 (5.69e-12) |
0.0358 (0.0915) |
1e-05 (7.57e-05) |
1e-05 (7.57e-05) |
0.00013 (0.000758) |
9.23e-06 (7.57e-05) |
0.177 (0.323) |
0.0401 (0.102) |
1e-05 (7.57e-05) |
0.932 (0.966) |
0.525 (0.656) |
0.00827 (0.0271) |
0.852 (0.927) |
amp 17q25 2 | 232 (27%) | 627 |
0.592 (0.723) |
0.0619 (0.147) |
0.00052 (0.00251) |
0.003 (0.0114) |
0.00017 (0.000968) |
0.214 (0.366) |
0.000821 (0.00382) |
0.514 (0.651) |
1e-05 (7.57e-05) |
0.987 (1.00) |
0.0926 (0.197) |
0.0121 (0.0379) |
0.228 (0.38) |
del 3p26 3 | 486 (57%) | 373 |
0.00113 (0.00513) |
0.786 (0.884) |
1e-05 (7.57e-05) |
2e-05 (0.000149) |
0.00885 (0.0288) |
0.133 (0.261) |
0.0684 (0.159) |
0.151 (0.288) |
1e-05 (7.57e-05) |
0.43 (0.59) |
0.0786 (0.175) |
1e-05 (7.57e-05) |
0.267 (0.423) |
del 11q21 | 60 (7%) | 799 |
0.00196 (0.0082) |
0.00478 (0.0167) |
0.00026 (0.00136) |
0.00041 (0.00206) |
0.00019 (0.00106) |
0.0998 (0.209) |
0.671 (0.793) |
0.0624 (0.147) |
0.00304 (0.0114) |
0.46 (0.619) |
0.886 (0.941) |
0.418 (0.578) |
0.349 (0.504) |
del 11q23 1 | 70 (8%) | 789 |
0.00373 (0.0136) |
0.00293 (0.0112) |
3e-05 (0.000214) |
1e-05 (7.57e-05) |
0.00047 (0.00229) |
0.112 (0.228) |
0.428 (0.59) |
0.0253 (0.0686) |
0.00361 (0.0134) |
0.669 (0.793) |
0.927 (0.965) |
0.27 (0.426) |
0.242 (0.397) |
del 13q12 13 | 148 (17%) | 711 |
0.0323 (0.0845) |
0.000423 (0.0021) |
1e-05 (7.57e-05) |
1e-05 (7.57e-05) |
0.0135 (0.041) |
0.228 (0.38) |
0.0212 (0.0604) |
0.316 (0.47) |
1e-05 (7.57e-05) |
0.751 (0.854) |
0.278 (0.432) |
0.103 (0.213) |
0.377 (0.539) |
del 13q14 2 | 148 (17%) | 711 |
0.0241 (0.0666) |
8.11e-05 (0.000501) |
1e-05 (7.57e-05) |
1e-05 (7.57e-05) |
0.015 (0.0449) |
0.132 (0.261) |
0.0125 (0.0389) |
0.379 (0.541) |
1e-05 (7.57e-05) |
0.914 (0.955) |
0.249 (0.407) |
0.104 (0.214) |
0.66 (0.791) |
del 18q22 2 | 152 (18%) | 707 |
6.48e-07 (5.47e-05) |
0.619 (0.749) |
1e-05 (7.57e-05) |
1e-05 (7.57e-05) |
0.0213 (0.0604) |
0.00917 (0.0294) |
1 (1.00) |
0.56 (0.693) |
0.318 (0.472) |
0.513 (0.651) |
0.117 (0.236) |
0.0746 (0.171) |
0.0894 (0.192) |
amp 1q32 1 | 81 (9%) | 778 |
0.000273 (0.00141) |
0.0313 (0.0827) |
3e-05 (0.000214) |
0.00019 (0.00106) |
0.0705 (0.163) |
0.137 (0.269) |
0.623 (0.752) |
0.297 (0.45) |
0.00282 (0.0108) |
0.336 (0.491) |
0.101 (0.212) |
0.149 (0.287) |
0.259 (0.415) |
amp xq11 2 | 128 (15%) | 731 |
0.0918 (0.196) |
0.468 (0.62) |
0.00471 (0.0167) |
0.00788 (0.0259) |
0.894 (0.945) |
0.564 (0.695) |
0.000237 (0.00127) |
0.0254 (0.0686) |
1e-05 (7.57e-05) |
0.742 (0.847) |
0.0193 (0.0556) |
0.184 (0.335) |
0.661 (0.791) |
del 3p12 2 | 334 (39%) | 525 |
0.00116 (0.00521) |
0.813 (0.902) |
0.0127 (0.039) |
0.00642 (0.0217) |
0.515 (0.651) |
0.731 (0.841) |
0.0884 (0.191) |
0.774 (0.874) |
1e-05 (7.57e-05) |
0.233 (0.385) |
0.0826 (0.182) |
0.00473 (0.0167) |
0.741 (0.847) |
del 4q34 3 | 111 (13%) | 748 |
7.22e-09 (8.79e-07) |
0.671 (0.793) |
1e-05 (7.57e-05) |
1e-05 (7.57e-05) |
0.0109 (0.0346) |
0.0143 (0.043) |
0.83 (0.911) |
0.885 (0.941) |
0.0318 (0.0836) |
0.401 (0.561) |
0.665 (0.793) |
0.0647 (0.151) |
0.482 (0.634) |
del 6q22 31 | 225 (26%) | 634 |
0.383 (0.543) |
0.124 (0.248) |
0.00013 (0.000758) |
4e-05 (0.000278) |
0.0357 (0.0915) |
1 (1.00) |
0.681 (0.803) |
0.107 (0.219) |
1e-05 (7.57e-05) |
0.206 (0.356) |
0.22 (0.372) |
0.00221 (0.00882) |
0.263 (0.42) |
del 19p13 3 | 40 (5%) | 819 |
8.5e-12 (2.16e-09) |
0.443 (0.601) |
6e-05 (0.00038) |
1e-05 (7.57e-05) |
0.00022 (0.00121) |
0.064 (0.15) |
0.864 (0.934) |
0.0779 (0.175) |
0.0287 (0.0763) |
0.464 (0.62) |
0.334 (0.49) |
0.716 (0.829) |
|
amp 3q26 32 | 185 (22%) | 674 |
0.414 (0.574) |
0.116 (0.236) |
0.21 (0.361) |
0.185 (0.336) |
0.0217 (0.061) |
0.00735 (0.0244) |
0.187 (0.337) |
0.107 (0.219) |
1e-05 (7.57e-05) |
0.38 (0.541) |
0.262 (0.419) |
0.0571 (0.138) |
0.704 (0.82) |
amp 5q35 1 | 372 (43%) | 487 |
0.189 (0.338) |
0.129 (0.256) |
0.00012 (0.000724) |
0.00911 (0.0294) |
0.0235 (0.0656) |
0.0161 (0.0467) |
0.307 (0.459) |
0.514 (0.651) |
1e-05 (7.57e-05) |
0.431 (0.59) |
0.274 (0.428) |
3e-05 (0.000214) |
0.873 (0.936) |
amp xp22 2 | 121 (14%) | 738 |
0.269 (0.425) |
0.392 (0.552) |
0.0233 (0.0654) |
0.0759 (0.173) |
0.896 (0.945) |
0.252 (0.409) |
0.00494 (0.017) |
0.0254 (0.0686) |
1e-05 (7.57e-05) |
0.826 (0.91) |
0.044 (0.11) |
0.32 (0.474) |
0.821 (0.907) |
amp xp11 4 | 129 (15%) | 730 |
0.236 (0.388) |
0.28 (0.434) |
0.00376 (0.0136) |
0.0259 (0.069) |
0.897 (0.945) |
0.133 (0.261) |
0.000532 (0.00254) |
0.0254 (0.0686) |
1e-05 (7.57e-05) |
0.832 (0.911) |
0.0579 (0.139) |
0.251 (0.408) |
0.522 (0.656) |
amp xq28 | 132 (15%) | 727 |
0.0777 (0.175) |
0.46 (0.619) |
0.0369 (0.094) |
0.0412 (0.104) |
0.908 (0.953) |
0.466 (0.62) |
0.016 (0.0465) |
0.00192 (0.00811) |
1e-05 (7.57e-05) |
0.855 (0.928) |
0.267 (0.423) |
0.162 (0.304) |
0.282 (0.435) |
del 1p36 31 | 203 (24%) | 656 |
0.396 (0.556) |
0.0774 (0.175) |
1e-05 (7.57e-05) |
1e-05 (7.57e-05) |
0.0685 (0.159) |
0.502 (0.645) |
0.496 (0.643) |
0.0152 (0.045) |
1e-05 (7.57e-05) |
0.344 (0.499) |
0.327 (0.482) |
0.603 (0.732) |
0.335 (0.49) |
del 1p31 1 | 161 (19%) | 698 |
0.511 (0.651) |
0.0352 (0.091) |
4e-05 (0.000278) |
5e-05 (0.000334) |
0.102 (0.213) |
0.885 (0.941) |
1 (1.00) |
0.229 (0.38) |
1e-05 (7.57e-05) |
0.473 (0.623) |
0.699 (0.819) |
0.397 (0.556) |
0.0856 (0.186) |
del 2q37 3 | 110 (13%) | 749 |
0.0153 (0.0451) |
0.00203 (0.00829) |
1e-05 (7.57e-05) |
1e-05 (7.57e-05) |
0.282 (0.435) |
0.0853 (0.186) |
0.516 (0.651) |
0.955 (0.986) |
1e-05 (7.57e-05) |
0.559 (0.692) |
0.866 (0.934) |
0.494 (0.642) |
1 (1.00) |
del 3p14 1 | 405 (47%) | 454 |
0.00206 (0.00829) |
0.91 (0.953) |
0.00023 (0.00124) |
6e-05 (0.00038) |
0.219 (0.372) |
0.565 (0.695) |
0.192 (0.341) |
0.286 (0.438) |
1e-05 (7.57e-05) |
0.34 (0.496) |
0.055 (0.133) |
0.00013 (0.000758) |
0.75 (0.854) |
del 6q26 | 230 (27%) | 629 |
0.302 (0.453) |
0.187 (0.337) |
6e-05 (0.00038) |
5e-05 (0.000334) |
0.0548 (0.133) |
1 (1.00) |
0.624 (0.752) |
0.086 (0.186) |
1e-05 (7.57e-05) |
0.206 (0.356) |
0.22 (0.372) |
0.00126 (0.0056) |
0.191 (0.34) |
del 6q26 | 231 (27%) | 628 |
0.298 (0.45) |
0.193 (0.341) |
8e-05 (0.000501) |
6e-05 (0.00038) |
0.0549 (0.133) |
1 (1.00) |
0.807 (0.899) |
0.086 (0.186) |
1e-05 (7.57e-05) |
0.206 (0.356) |
0.22 (0.372) |
0.00323 (0.012) |
0.192 (0.341) |
del 8p23 2 | 181 (21%) | 678 |
0.000909 (0.00419) |
0.501 (0.645) |
0.00201 (0.00829) |
0.00183 (0.0078) |
0.47 (0.62) |
0.0257 (0.0689) |
0.791 (0.887) |
0.434 (0.593) |
1e-05 (7.57e-05) |
0.491 (0.64) |
0.524 (0.656) |
0.00376 (0.0136) |
0.156 (0.295) |
amp 7q31 2 | 364 (42%) | 495 |
0.91 (0.953) |
0.376 (0.539) |
0.0134 (0.041) |
0.793 (0.887) |
0.228 (0.38) |
0.00198 (0.00821) |
7.63e-06 (7.57e-05) |
0.292 (0.445) |
1e-05 (7.57e-05) |
0.411 (0.571) |
0.0146 (0.0439) |
0.186 (0.337) |
0.259 (0.415) |
del 1q43 | 112 (13%) | 747 |
0.0476 (0.118) |
0.00276 (0.0107) |
0.00037 (0.00188) |
0.00154 (0.00662) |
0.275 (0.429) |
0.17 (0.314) |
0.164 (0.305) |
0.139 (0.272) |
1e-05 (7.57e-05) |
0.831 (0.911) |
0.601 (0.731) |
0.226 (0.38) |
0.146 (0.282) |
del 5p15 33 | 31 (4%) | 828 |
0.948 (0.981) |
0.00445 (0.016) |
0.00148 (0.00647) |
0.00057 (0.0027) |
0.00573 (0.0196) |
0.741 (0.847) |
0.176 (0.323) |
0.777 (0.875) |
1e-05 (7.57e-05) |
0.469 (0.62) |
0.253 (0.41) |
0.575 (0.706) |
0.154 (0.291) |
del 10q23 31 | 162 (19%) | 697 |
0.707 (0.822) |
0.0425 (0.107) |
1e-05 (7.57e-05) |
1e-05 (7.57e-05) |
0.341 (0.496) |
0.888 (0.941) |
0.713 (0.827) |
0.283 (0.435) |
1e-05 (7.57e-05) |
0.214 (0.366) |
0.223 (0.375) |
0.0994 (0.209) |
0.385 (0.544) |
del xp22 2 | 123 (14%) | 736 |
0.918 (0.958) |
0.00136 (0.006) |
0.0001 (0.000611) |
0.00025 (0.00132) |
0.0948 (0.201) |
0.867 (0.934) |
0.538 (0.668) |
0.718 (0.829) |
1e-05 (7.57e-05) |
0.813 (0.902) |
0.291 (0.445) |
0.152 (0.289) |
0.46 (0.619) |
amp 19p13 2 | 97 (11%) | 762 |
0.957 (0.986) |
0.436 (0.594) |
0.00152 (0.00659) |
0.00247 (0.00978) |
0.593 (0.723) |
0.0156 (0.0456) |
0.17 (0.314) |
0.301 (0.453) |
0.00034 (0.00174) |
0.404 (0.563) |
0.768 (0.87) |
0.507 (0.651) |
0.803 (0.897) |
del 16q23 3 | 36 (4%) | 823 |
9.39e-06 (7.57e-05) |
0.724 (0.834) |
0.00647 (0.0217) |
0.00014 (0.000807) |
0.00046 (0.00226) |
0.353 (0.508) |
1 (1.00) |
0.489 (0.64) |
0.151 (0.288) |
0.168 (0.313) |
0.82 (0.907) |
0.439 (0.596) |
1 (1.00) |
amp 2q32 1 | 133 (15%) | 726 |
0.843 (0.921) |
0.205 (0.356) |
0.257 (0.414) |
0.385 (0.544) |
0.0752 (0.172) |
0.876 (0.937) |
0.273 (0.428) |
0.467 (0.62) |
0.00253 (0.00994) |
0.85 (0.927) |
0.461 (0.619) |
0.491 (0.64) |
0.656 (0.788) |
amp 10p14 | 33 (4%) | 826 |
0.67 (0.793) |
0.311 (0.463) |
0.126 (0.252) |
0.00061 (0.00286) |
0.0809 (0.179) |
0.576 (0.706) |
1 (1.00) |
0.497 (0.643) |
0.514 (0.651) |
0.764 (0.866) |
0.2 (0.351) |
1 (1.00) |
P value = 0.000273 (logrank test), Q value = 0.0014
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 843 | 211 | 0.1 - 194.8 (30.5) |
AMP PEAK 1(1Q32.1) MUTATED | 80 | 34 | 0.4 - 94.7 (26.8) |
AMP PEAK 1(1Q32.1) WILD-TYPE | 763 | 177 | 0.1 - 194.8 (30.7) |
P value = 0.0313 (Wilcoxon-test), Q value = 0.083
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 853 | 60.1 (12.6) |
AMP PEAK 1(1Q32.1) MUTATED | 79 | 62.5 (12.2) |
AMP PEAK 1(1Q32.1) WILD-TYPE | 774 | 59.9 (12.6) |
P value = 3e-05 (Fisher's exact test), Q value = 0.00021
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
AMP PEAK 1(1Q32.1) MUTATED | 24 | 10 | 32 | 15 |
AMP PEAK 1(1Q32.1) WILD-TYPE | 424 | 93 | 158 | 85 |
P value = 0.00019 (Fisher's exact test), Q value = 0.0011
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
AMP PEAK 1(1Q32.1) MUTATED | 27 | 12 | 41 | 1 |
AMP PEAK 1(1Q32.1) WILD-TYPE | 435 | 111 | 210 | 14 |
P value = 0.0705 (Fisher's exact test), Q value = 0.16
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 317 | 43 | 6 |
AMP PEAK 1(1Q32.1) MUTATED | 35 | 10 | 1 |
AMP PEAK 1(1Q32.1) WILD-TYPE | 282 | 33 | 5 |
P value = 0.00282 (Fisher's exact test), Q value = 0.011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
AMP PEAK 1(1Q32.1) MUTATED | 1 | 62 | 18 |
AMP PEAK 1(1Q32.1) WILD-TYPE | 65 | 462 | 251 |
P value = 0.101 (Wilcoxon-test), Q value = 0.21
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 67 | 1973.4 (16.4) |
AMP PEAK 1(1Q32.1) MUTATED | 3 | 1989.0 (19.2) |
AMP PEAK 1(1Q32.1) WILD-TYPE | 64 | 1972.7 (16.1) |
P value = 0.0752 (Fisher's exact test), Q value = 0.17
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 317 | 43 | 6 |
AMP PEAK 2(2Q32.1) MUTATED | 47 | 11 | 2 |
AMP PEAK 2(2Q32.1) WILD-TYPE | 270 | 32 | 4 |
P value = 0.00253 (Fisher's exact test), Q value = 0.0099
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
AMP PEAK 2(2Q32.1) MUTATED | 2 | 80 | 51 |
AMP PEAK 2(2Q32.1) WILD-TYPE | 64 | 444 | 218 |
P value = 0.116 (Wilcoxon-test), Q value = 0.24
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 853 | 60.1 (12.6) |
AMP PEAK 3(3Q26.32) MUTATED | 182 | 61.5 (12.1) |
AMP PEAK 3(3Q26.32) WILD-TYPE | 671 | 59.7 (12.7) |
P value = 0.0217 (Fisher's exact test), Q value = 0.061
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 317 | 43 | 6 |
AMP PEAK 3(3Q26.32) MUTATED | 57 | 15 | 0 |
AMP PEAK 3(3Q26.32) WILD-TYPE | 260 | 28 | 6 |
P value = 0.00735 (Fisher's exact test), Q value = 0.024
nPatients | 0 | 1 |
---|---|---|
ALL | 542 | 89 |
AMP PEAK 3(3Q26.32) MUTATED | 90 | 26 |
AMP PEAK 3(3Q26.32) WILD-TYPE | 452 | 63 |
P value = 0.107 (Wilcoxon-test), Q value = 0.22
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 115 | 90.3 (17.6) |
AMP PEAK 3(3Q26.32) MUTATED | 31 | 94.8 (6.8) |
AMP PEAK 3(3Q26.32) WILD-TYPE | 84 | 88.6 (19.9) |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
AMP PEAK 3(3Q26.32) MUTATED | 6 | 86 | 93 |
AMP PEAK 3(3Q26.32) WILD-TYPE | 60 | 438 | 176 |
P value = 0.0571 (Fisher's exact test), Q value = 0.14
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 116 | 702 |
AMP PEAK 3(3Q26.32) MUTATED | 2 | 1 | 24 | 149 |
AMP PEAK 3(3Q26.32) WILD-TYPE | 0 | 14 | 92 | 553 |
P value = 0.00012 (Fisher's exact test), Q value = 0.00072
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
AMP PEAK 4(5Q35.1) MUTATED | 172 | 42 | 93 | 62 |
AMP PEAK 4(5Q35.1) WILD-TYPE | 276 | 61 | 97 | 38 |
P value = 0.00911 (Fisher's exact test), Q value = 0.029
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
AMP PEAK 4(5Q35.1) MUTATED | 179 | 55 | 130 | 7 |
AMP PEAK 4(5Q35.1) WILD-TYPE | 283 | 68 | 121 | 8 |
P value = 0.0235 (Fisher's exact test), Q value = 0.066
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 317 | 43 | 6 |
AMP PEAK 4(5Q35.1) MUTATED | 161 | 14 | 1 |
AMP PEAK 4(5Q35.1) WILD-TYPE | 156 | 29 | 5 |
P value = 0.0161 (Fisher's exact test), Q value = 0.047
nPatients | 0 | 1 |
---|---|---|
ALL | 542 | 89 |
AMP PEAK 4(5Q35.1) MUTATED | 278 | 58 |
AMP PEAK 4(5Q35.1) WILD-TYPE | 264 | 31 |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
AMP PEAK 4(5Q35.1) MUTATED | 8 | 330 | 34 |
AMP PEAK 4(5Q35.1) WILD-TYPE | 58 | 194 | 235 |
P value = 3e-05 (Fisher's exact test), Q value = 0.00021
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 116 | 702 |
AMP PEAK 4(5Q35.1) MUTATED | 0 | 5 | 29 | 331 |
AMP PEAK 4(5Q35.1) WILD-TYPE | 2 | 10 | 87 | 371 |
P value = 0.0134 (Fisher's exact test), Q value = 0.041
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
AMP PEAK 5(7Q31.2) MUTATED | 193 | 37 | 68 | 54 |
AMP PEAK 5(7Q31.2) WILD-TYPE | 255 | 66 | 122 | 46 |
P value = 0.00198 (Fisher's exact test), Q value = 0.0082
nPatients | 0 | 1 |
---|---|---|
ALL | 542 | 89 |
AMP PEAK 5(7Q31.2) MUTATED | 189 | 47 |
AMP PEAK 5(7Q31.2) WILD-TYPE | 353 | 42 |
P value = 7.63e-06 (Fisher's exact test), Q value = 7.6e-05
nPatients | FEMALE | MALE |
---|---|---|
ALL | 287 | 572 |
AMP PEAK 5(7Q31.2) MUTATED | 91 | 273 |
AMP PEAK 5(7Q31.2) WILD-TYPE | 196 | 299 |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
AMP PEAK 5(7Q31.2) MUTATED | 25 | 174 | 165 |
AMP PEAK 5(7Q31.2) WILD-TYPE | 41 | 350 | 104 |
P value = 0.0146 (Wilcoxon-test), Q value = 0.044
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 67 | 1973.4 (16.4) |
AMP PEAK 5(7Q31.2) MUTATED | 36 | 1969.0 (15.8) |
AMP PEAK 5(7Q31.2) WILD-TYPE | 31 | 1978.5 (15.8) |
P value = 0.00646 (logrank test), Q value = 0.022
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 843 | 211 | 0.1 - 194.8 (30.5) |
AMP PEAK 6(8Q24.22) MUTATED | 120 | 40 | 0.2 - 152.0 (25.8) |
AMP PEAK 6(8Q24.22) WILD-TYPE | 723 | 171 | 0.1 - 194.8 (31.2) |
P value = 0.0485 (Wilcoxon-test), Q value = 0.12
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 853 | 60.1 (12.6) |
AMP PEAK 6(8Q24.22) MUTATED | 121 | 62.1 (12.7) |
AMP PEAK 6(8Q24.22) WILD-TYPE | 732 | 59.8 (12.5) |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
AMP PEAK 6(8Q24.22) MUTATED | 35 | 22 | 37 | 25 |
AMP PEAK 6(8Q24.22) WILD-TYPE | 413 | 81 | 153 | 75 |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
AMP PEAK 6(8Q24.22) MUTATED | 36 | 23 | 56 | 4 |
AMP PEAK 6(8Q24.22) WILD-TYPE | 426 | 100 | 195 | 11 |
P value = 0.0615 (Fisher's exact test), Q value = 0.15
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 317 | 43 | 6 |
AMP PEAK 6(8Q24.22) MUTATED | 50 | 12 | 2 |
AMP PEAK 6(8Q24.22) WILD-TYPE | 267 | 31 | 4 |
P value = 0.00979 (Fisher's exact test), Q value = 0.031
nPatients | 0 | 1 |
---|---|---|
ALL | 542 | 89 |
AMP PEAK 6(8Q24.22) MUTATED | 73 | 22 |
AMP PEAK 6(8Q24.22) WILD-TYPE | 469 | 67 |
P value = 0.00092 (Fisher's exact test), Q value = 0.0042
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
AMP PEAK 6(8Q24.22) MUTATED | 18 | 78 | 25 |
AMP PEAK 6(8Q24.22) WILD-TYPE | 48 | 446 | 244 |
P value = 0.118 (Wilcoxon-test), Q value = 0.24
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 91 | 30.8 (26.2) |
AMP PEAK 6(8Q24.22) MUTATED | 12 | 20.8 (15.9) |
AMP PEAK 6(8Q24.22) WILD-TYPE | 79 | 32.3 (27.2) |
P value = 0.00454 (Fisher's exact test), Q value = 0.016
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 116 | 702 |
AMP PEAK 6(8Q24.22) MUTATED | 0 | 4 | 6 | 108 |
AMP PEAK 6(8Q24.22) WILD-TYPE | 2 | 11 | 110 | 594 |
P value = 0.00061 (Fisher's exact test), Q value = 0.0029
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
AMP PEAK 7(10P14) MUTATED | 13 | 9 | 7 | 4 |
AMP PEAK 7(10P14) WILD-TYPE | 449 | 114 | 244 | 11 |
P value = 0.0809 (Fisher's exact test), Q value = 0.18
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 317 | 43 | 6 |
AMP PEAK 7(10P14) MUTATED | 12 | 5 | 0 |
AMP PEAK 7(10P14) WILD-TYPE | 305 | 38 | 6 |
P value = 0.0619 (Wilcoxon-test), Q value = 0.15
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 853 | 60.1 (12.6) |
AMP PEAK 8(17Q25.2) MUTATED | 229 | 61.4 (12.3) |
AMP PEAK 8(17Q25.2) WILD-TYPE | 624 | 59.6 (12.6) |
P value = 0.00052 (Fisher's exact test), Q value = 0.0025
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
AMP PEAK 8(17Q25.2) MUTATED | 144 | 21 | 42 | 15 |
AMP PEAK 8(17Q25.2) WILD-TYPE | 304 | 82 | 148 | 85 |
P value = 0.003 (Fisher's exact test), Q value = 0.011
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
AMP PEAK 8(17Q25.2) MUTATED | 148 | 28 | 50 | 4 |
AMP PEAK 8(17Q25.2) WILD-TYPE | 314 | 95 | 201 | 11 |
P value = 0.00017 (Fisher's exact test), Q value = 0.00097
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 317 | 43 | 6 |
AMP PEAK 8(17Q25.2) MUTATED | 46 | 16 | 3 |
AMP PEAK 8(17Q25.2) WILD-TYPE | 271 | 27 | 3 |
P value = 0.000821 (Fisher's exact test), Q value = 0.0038
nPatients | FEMALE | MALE |
---|---|---|
ALL | 287 | 572 |
AMP PEAK 8(17Q25.2) MUTATED | 57 | 175 |
AMP PEAK 8(17Q25.2) WILD-TYPE | 230 | 397 |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
AMP PEAK 8(17Q25.2) MUTATED | 1 | 42 | 189 |
AMP PEAK 8(17Q25.2) WILD-TYPE | 65 | 482 | 80 |
P value = 0.0926 (Wilcoxon-test), Q value = 0.2
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 67 | 1973.4 (16.4) |
AMP PEAK 8(17Q25.2) MUTATED | 33 | 1970.4 (16.0) |
AMP PEAK 8(17Q25.2) WILD-TYPE | 34 | 1976.3 (16.5) |
P value = 0.0121 (Fisher's exact test), Q value = 0.038
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 116 | 702 |
AMP PEAK 8(17Q25.2) MUTATED | 2 | 6 | 39 | 175 |
AMP PEAK 8(17Q25.2) WILD-TYPE | 0 | 9 | 77 | 527 |
P value = 0.00152 (Fisher's exact test), Q value = 0.0066
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
AMP PEAK 9(19P13.2) MUTATED | 35 | 18 | 19 | 19 |
AMP PEAK 9(19P13.2) WILD-TYPE | 413 | 85 | 171 | 81 |
P value = 0.00247 (Fisher's exact test), Q value = 0.0098
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
AMP PEAK 9(19P13.2) MUTATED | 37 | 23 | 33 | 3 |
AMP PEAK 9(19P13.2) WILD-TYPE | 425 | 100 | 218 | 12 |
P value = 0.0156 (Fisher's exact test), Q value = 0.046
nPatients | 0 | 1 |
---|---|---|
ALL | 542 | 89 |
AMP PEAK 9(19P13.2) MUTATED | 52 | 17 |
AMP PEAK 9(19P13.2) WILD-TYPE | 490 | 72 |
P value = 0.00034 (Fisher's exact test), Q value = 0.0017
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
AMP PEAK 9(19P13.2) MUTATED | 18 | 49 | 30 |
AMP PEAK 9(19P13.2) WILD-TYPE | 48 | 475 | 239 |
P value = 0.0233 (Fisher's exact test), Q value = 0.065
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
AMP PEAK 10(XP22.2) MUTATED | 72 | 14 | 14 | 15 |
AMP PEAK 10(XP22.2) WILD-TYPE | 376 | 89 | 176 | 85 |
P value = 0.0759 (Fisher's exact test), Q value = 0.17
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
AMP PEAK 10(XP22.2) MUTATED | 73 | 19 | 24 | 3 |
AMP PEAK 10(XP22.2) WILD-TYPE | 389 | 104 | 227 | 12 |
P value = 0.00494 (Fisher's exact test), Q value = 0.017
nPatients | FEMALE | MALE |
---|---|---|
ALL | 287 | 572 |
AMP PEAK 10(XP22.2) MUTATED | 27 | 94 |
AMP PEAK 10(XP22.2) WILD-TYPE | 260 | 478 |
P value = 0.0254 (Wilcoxon-test), Q value = 0.069
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 115 | 90.3 (17.6) |
AMP PEAK 10(XP22.2) MUTATED | 26 | 92.3 (20.3) |
AMP PEAK 10(XP22.2) WILD-TYPE | 89 | 89.7 (16.8) |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
AMP PEAK 10(XP22.2) MUTATED | 7 | 30 | 84 |
AMP PEAK 10(XP22.2) WILD-TYPE | 59 | 494 | 185 |
P value = 0.044 (Wilcoxon-test), Q value = 0.11
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 67 | 1973.4 (16.4) |
AMP PEAK 10(XP22.2) MUTATED | 14 | 1966.4 (14.1) |
AMP PEAK 10(XP22.2) WILD-TYPE | 53 | 1975.3 (16.6) |
P value = 0.00376 (Fisher's exact test), Q value = 0.014
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
AMP PEAK 11(XP11.4) MUTATED | 78 | 14 | 13 | 16 |
AMP PEAK 11(XP11.4) WILD-TYPE | 370 | 89 | 177 | 84 |
P value = 0.0259 (Fisher's exact test), Q value = 0.069
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
AMP PEAK 11(XP11.4) MUTATED | 80 | 20 | 24 | 3 |
AMP PEAK 11(XP11.4) WILD-TYPE | 382 | 103 | 227 | 12 |
P value = 0.000532 (Fisher's exact test), Q value = 0.0025
nPatients | FEMALE | MALE |
---|---|---|
ALL | 287 | 572 |
AMP PEAK 11(XP11.4) MUTATED | 26 | 103 |
AMP PEAK 11(XP11.4) WILD-TYPE | 261 | 469 |
P value = 0.0254 (Wilcoxon-test), Q value = 0.069
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 115 | 90.3 (17.6) |
AMP PEAK 11(XP11.4) MUTATED | 26 | 92.3 (20.3) |
AMP PEAK 11(XP11.4) WILD-TYPE | 89 | 89.7 (16.8) |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
AMP PEAK 11(XP11.4) MUTATED | 7 | 32 | 90 |
AMP PEAK 11(XP11.4) WILD-TYPE | 59 | 492 | 179 |
P value = 0.0579 (Wilcoxon-test), Q value = 0.14
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 67 | 1973.4 (16.4) |
AMP PEAK 11(XP11.4) MUTATED | 15 | 1966.9 (13.8) |
AMP PEAK 11(XP11.4) WILD-TYPE | 52 | 1975.3 (16.8) |
P value = 0.0918 (logrank test), Q value = 0.2
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 843 | 211 | 0.1 - 194.8 (30.5) |
AMP PEAK 12(XQ11.2) MUTATED | 122 | 19 | 0.1 - 194.8 (25.6) |
AMP PEAK 12(XQ11.2) WILD-TYPE | 721 | 192 | 0.1 - 152.0 (31.3) |
P value = 0.00471 (Fisher's exact test), Q value = 0.017
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
AMP PEAK 12(XQ11.2) MUTATED | 80 | 14 | 14 | 12 |
AMP PEAK 12(XQ11.2) WILD-TYPE | 368 | 89 | 176 | 88 |
P value = 0.00788 (Fisher's exact test), Q value = 0.026
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
AMP PEAK 12(XQ11.2) MUTATED | 82 | 20 | 22 | 2 |
AMP PEAK 12(XQ11.2) WILD-TYPE | 380 | 103 | 229 | 13 |
P value = 0.000237 (Fisher's exact test), Q value = 0.0013
nPatients | FEMALE | MALE |
---|---|---|
ALL | 287 | 572 |
AMP PEAK 12(XQ11.2) MUTATED | 25 | 103 |
AMP PEAK 12(XQ11.2) WILD-TYPE | 262 | 469 |
P value = 0.0254 (Wilcoxon-test), Q value = 0.069
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 115 | 90.3 (17.6) |
AMP PEAK 12(XQ11.2) MUTATED | 26 | 92.3 (20.3) |
AMP PEAK 12(XQ11.2) WILD-TYPE | 89 | 89.7 (16.8) |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
AMP PEAK 12(XQ11.2) MUTATED | 7 | 28 | 93 |
AMP PEAK 12(XQ11.2) WILD-TYPE | 59 | 496 | 176 |
P value = 0.0193 (Wilcoxon-test), Q value = 0.056
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 67 | 1973.4 (16.4) |
AMP PEAK 12(XQ11.2) MUTATED | 16 | 1965.3 (14.8) |
AMP PEAK 12(XQ11.2) WILD-TYPE | 51 | 1975.9 (16.2) |
P value = 0.0777 (logrank test), Q value = 0.17
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 843 | 211 | 0.1 - 194.8 (30.5) |
AMP PEAK 13(XQ28) MUTATED | 126 | 20 | 0.1 - 194.8 (25.5) |
AMP PEAK 13(XQ28) WILD-TYPE | 717 | 191 | 0.1 - 152.0 (31.3) |
P value = 0.0369 (Fisher's exact test), Q value = 0.094
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
AMP PEAK 13(XQ28) MUTATED | 80 | 12 | 18 | 14 |
AMP PEAK 13(XQ28) WILD-TYPE | 368 | 91 | 172 | 86 |
P value = 0.0412 (Fisher's exact test), Q value = 0.1
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
AMP PEAK 13(XQ28) MUTATED | 83 | 19 | 26 | 3 |
AMP PEAK 13(XQ28) WILD-TYPE | 379 | 104 | 225 | 12 |
P value = 0.016 (Fisher's exact test), Q value = 0.047
nPatients | FEMALE | MALE |
---|---|---|
ALL | 287 | 572 |
AMP PEAK 13(XQ28) MUTATED | 32 | 100 |
AMP PEAK 13(XQ28) WILD-TYPE | 255 | 472 |
P value = 0.00192 (Wilcoxon-test), Q value = 0.0081
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 115 | 90.3 (17.6) |
AMP PEAK 13(XQ28) MUTATED | 24 | 97.1 (5.5) |
AMP PEAK 13(XQ28) WILD-TYPE | 91 | 88.5 (19.2) |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
AMP PEAK 13(XQ28) MUTATED | 8 | 37 | 87 |
AMP PEAK 13(XQ28) WILD-TYPE | 58 | 487 | 182 |
P value = 0.0774 (Wilcoxon-test), Q value = 0.17
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 853 | 60.1 (12.6) |
DEL PEAK 1(1P36.31) MUTATED | 202 | 58.4 (13.7) |
DEL PEAK 1(1P36.31) WILD-TYPE | 651 | 60.6 (12.2) |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
DEL PEAK 1(1P36.31) MUTATED | 71 | 38 | 60 | 29 |
DEL PEAK 1(1P36.31) WILD-TYPE | 377 | 65 | 130 | 71 |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
DEL PEAK 1(1P36.31) MUTATED | 77 | 45 | 73 | 6 |
DEL PEAK 1(1P36.31) WILD-TYPE | 385 | 78 | 178 | 9 |
P value = 0.0685 (Fisher's exact test), Q value = 0.16
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 317 | 43 | 6 |
DEL PEAK 1(1P36.31) MUTATED | 92 | 19 | 3 |
DEL PEAK 1(1P36.31) WILD-TYPE | 225 | 24 | 3 |
P value = 0.0152 (Wilcoxon-test), Q value = 0.045
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 115 | 90.3 (17.6) |
DEL PEAK 1(1P36.31) MUTATED | 26 | 86.2 (19.8) |
DEL PEAK 1(1P36.31) WILD-TYPE | 89 | 91.5 (16.8) |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
DEL PEAK 1(1P36.31) MUTATED | 53 | 101 | 49 |
DEL PEAK 1(1P36.31) WILD-TYPE | 13 | 423 | 220 |
P value = 0.0352 (Wilcoxon-test), Q value = 0.091
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 853 | 60.1 (12.6) |
DEL PEAK 2(1P31.1) MUTATED | 161 | 57.8 (13.8) |
DEL PEAK 2(1P31.1) WILD-TYPE | 692 | 60.6 (12.2) |
P value = 4e-05 (Fisher's exact test), Q value = 0.00028
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
DEL PEAK 2(1P31.1) MUTATED | 59 | 34 | 43 | 22 |
DEL PEAK 2(1P31.1) WILD-TYPE | 389 | 69 | 147 | 78 |
P value = 5e-05 (Fisher's exact test), Q value = 0.00033
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
DEL PEAK 2(1P31.1) MUTATED | 64 | 38 | 52 | 6 |
DEL PEAK 2(1P31.1) WILD-TYPE | 398 | 85 | 199 | 9 |
P value = 0.102 (Fisher's exact test), Q value = 0.21
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 317 | 43 | 6 |
DEL PEAK 2(1P31.1) MUTATED | 72 | 14 | 3 |
DEL PEAK 2(1P31.1) WILD-TYPE | 245 | 29 | 3 |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
DEL PEAK 2(1P31.1) MUTATED | 53 | 76 | 32 |
DEL PEAK 2(1P31.1) WILD-TYPE | 13 | 448 | 237 |
P value = 0.0856 (Fisher's exact test), Q value = 0.19
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 42 | 597 |
DEL PEAK 2(1P31.1) MUTATED | 11 | 94 |
DEL PEAK 2(1P31.1) WILD-TYPE | 31 | 503 |
P value = 0.0476 (logrank test), Q value = 0.12
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 843 | 211 | 0.1 - 194.8 (30.5) |
DEL PEAK 3(1Q43) MUTATED | 111 | 26 | 0.1 - 152.0 (47.2) |
DEL PEAK 3(1Q43) WILD-TYPE | 732 | 185 | 0.1 - 194.8 (29.0) |
P value = 0.00276 (Wilcoxon-test), Q value = 0.011
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 853 | 60.1 (12.6) |
DEL PEAK 3(1Q43) MUTATED | 112 | 56.4 (14.3) |
DEL PEAK 3(1Q43) WILD-TYPE | 741 | 60.7 (12.2) |
P value = 0.00037 (Fisher's exact test), Q value = 0.0019
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
DEL PEAK 3(1Q43) MUTATED | 46 | 28 | 23 | 11 |
DEL PEAK 3(1Q43) WILD-TYPE | 402 | 75 | 167 | 89 |
P value = 0.00154 (Fisher's exact test), Q value = 0.0066
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
DEL PEAK 3(1Q43) MUTATED | 47 | 28 | 31 | 4 |
DEL PEAK 3(1Q43) WILD-TYPE | 415 | 95 | 220 | 11 |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
DEL PEAK 3(1Q43) MUTATED | 51 | 42 | 19 |
DEL PEAK 3(1Q43) WILD-TYPE | 15 | 482 | 250 |
P value = 0.0153 (logrank test), Q value = 0.045
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 843 | 211 | 0.1 - 194.8 (30.5) |
DEL PEAK 4(2Q37.3) MUTATED | 108 | 21 | 0.4 - 152.0 (42.7) |
DEL PEAK 4(2Q37.3) WILD-TYPE | 735 | 190 | 0.1 - 194.8 (29.0) |
P value = 0.00203 (Wilcoxon-test), Q value = 0.0083
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 853 | 60.1 (12.6) |
DEL PEAK 4(2Q37.3) MUTATED | 109 | 56.4 (14.0) |
DEL PEAK 4(2Q37.3) WILD-TYPE | 744 | 60.6 (12.3) |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
DEL PEAK 4(2Q37.3) MUTATED | 38 | 32 | 28 | 10 |
DEL PEAK 4(2Q37.3) WILD-TYPE | 410 | 71 | 162 | 90 |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
DEL PEAK 4(2Q37.3) MUTATED | 38 | 34 | 34 | 3 |
DEL PEAK 4(2Q37.3) WILD-TYPE | 424 | 89 | 217 | 12 |
P value = 0.0853 (Fisher's exact test), Q value = 0.19
nPatients | 0 | 1 |
---|---|---|
ALL | 542 | 89 |
DEL PEAK 4(2Q37.3) MUTATED | 75 | 6 |
DEL PEAK 4(2Q37.3) WILD-TYPE | 467 | 83 |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
DEL PEAK 4(2Q37.3) MUTATED | 49 | 50 | 11 |
DEL PEAK 4(2Q37.3) WILD-TYPE | 17 | 474 | 258 |
P value = 0.00113 (logrank test), Q value = 0.0051
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 843 | 211 | 0.1 - 194.8 (30.5) |
DEL PEAK 5(3P26.3) MUTATED | 485 | 150 | 0.1 - 141.7 (36.4) |
DEL PEAK 5(3P26.3) WILD-TYPE | 358 | 61 | 0.1 - 194.8 (25.9) |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
DEL PEAK 5(3P26.3) MUTATED | 227 | 57 | 131 | 71 |
DEL PEAK 5(3P26.3) WILD-TYPE | 221 | 46 | 59 | 29 |
P value = 2e-05 (Fisher's exact test), Q value = 0.00015
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
DEL PEAK 5(3P26.3) MUTATED | 233 | 71 | 175 | 7 |
DEL PEAK 5(3P26.3) WILD-TYPE | 229 | 52 | 76 | 8 |
P value = 0.00885 (Fisher's exact test), Q value = 0.029
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 317 | 43 | 6 |
DEL PEAK 5(3P26.3) MUTATED | 212 | 23 | 1 |
DEL PEAK 5(3P26.3) WILD-TYPE | 105 | 20 | 5 |
P value = 0.0684 (Fisher's exact test), Q value = 0.16
nPatients | FEMALE | MALE |
---|---|---|
ALL | 287 | 572 |
DEL PEAK 5(3P26.3) MUTATED | 175 | 311 |
DEL PEAK 5(3P26.3) WILD-TYPE | 112 | 261 |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
DEL PEAK 5(3P26.3) MUTATED | 10 | 453 | 23 |
DEL PEAK 5(3P26.3) WILD-TYPE | 56 | 71 | 246 |
P value = 0.0786 (Wilcoxon-test), Q value = 0.18
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 67 | 1973.4 (16.4) |
DEL PEAK 5(3P26.3) MUTATED | 17 | 1979.4 (18.6) |
DEL PEAK 5(3P26.3) WILD-TYPE | 50 | 1971.4 (15.3) |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 116 | 702 |
DEL PEAK 5(3P26.3) MUTATED | 0 | 7 | 41 | 429 |
DEL PEAK 5(3P26.3) WILD-TYPE | 2 | 8 | 75 | 273 |
P value = 7.97e-06 (logrank test), Q value = 7.6e-05
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 843 | 211 | 0.1 - 194.8 (30.5) |
DEL PEAK 6(3P21.2) MUTATED | 498 | 160 | 0.1 - 141.7 (35.1) |
DEL PEAK 6(3P21.2) WILD-TYPE | 345 | 51 | 0.1 - 194.8 (26.4) |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
DEL PEAK 6(3P21.2) MUTATED | 227 | 57 | 137 | 78 |
DEL PEAK 6(3P21.2) WILD-TYPE | 221 | 46 | 53 | 22 |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
DEL PEAK 6(3P21.2) MUTATED | 233 | 71 | 188 | 7 |
DEL PEAK 6(3P21.2) WILD-TYPE | 229 | 52 | 63 | 8 |
P value = 0.0986 (Fisher's exact test), Q value = 0.21
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 317 | 43 | 6 |
DEL PEAK 6(3P21.2) MUTATED | 218 | 26 | 2 |
DEL PEAK 6(3P21.2) WILD-TYPE | 99 | 17 | 4 |
P value = 0.0049 (Fisher's exact test), Q value = 0.017
nPatients | 0 | 1 |
---|---|---|
ALL | 542 | 89 |
DEL PEAK 6(3P21.2) MUTATED | 379 | 75 |
DEL PEAK 6(3P21.2) WILD-TYPE | 163 | 14 |
P value = 0.0596 (Wilcoxon-test), Q value = 0.14
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 115 | 90.3 (17.6) |
DEL PEAK 6(3P21.2) MUTATED | 48 | 86.0 (24.0) |
DEL PEAK 6(3P21.2) WILD-TYPE | 67 | 93.3 (10.1) |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
DEL PEAK 6(3P21.2) MUTATED | 11 | 463 | 25 |
DEL PEAK 6(3P21.2) WILD-TYPE | 55 | 61 | 244 |
P value = 0.0343 (Wilcoxon-test), Q value = 0.089
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 67 | 1973.4 (16.4) |
DEL PEAK 6(3P21.2) MUTATED | 18 | 1980.1 (17.8) |
DEL PEAK 6(3P21.2) WILD-TYPE | 49 | 1971.0 (15.3) |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 116 | 702 |
DEL PEAK 6(3P21.2) MUTATED | 0 | 8 | 41 | 442 |
DEL PEAK 6(3P21.2) WILD-TYPE | 2 | 7 | 75 | 260 |
P value = 0.00206 (logrank test), Q value = 0.0083
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 843 | 211 | 0.1 - 194.8 (30.5) |
DEL PEAK 7(3P14.1) MUTATED | 405 | 128 | 0.1 - 141.7 (36.4) |
DEL PEAK 7(3P14.1) WILD-TYPE | 438 | 83 | 0.1 - 194.8 (27.1) |
P value = 0.00023 (Fisher's exact test), Q value = 0.0012
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
DEL PEAK 7(3P14.1) MUTATED | 187 | 49 | 112 | 57 |
DEL PEAK 7(3P14.1) WILD-TYPE | 261 | 54 | 78 | 43 |
P value = 6e-05 (Fisher's exact test), Q value = 0.00038
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
DEL PEAK 7(3P14.1) MUTATED | 191 | 60 | 149 | 5 |
DEL PEAK 7(3P14.1) WILD-TYPE | 271 | 63 | 102 | 10 |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
DEL PEAK 7(3P14.1) MUTATED | 11 | 371 | 23 |
DEL PEAK 7(3P14.1) WILD-TYPE | 55 | 153 | 246 |
P value = 0.055 (Wilcoxon-test), Q value = 0.13
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 67 | 1973.4 (16.4) |
DEL PEAK 7(3P14.1) MUTATED | 15 | 1980.1 (18.7) |
DEL PEAK 7(3P14.1) WILD-TYPE | 52 | 1971.5 (15.3) |
P value = 0.00013 (Fisher's exact test), Q value = 0.00076
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 116 | 702 |
DEL PEAK 7(3P14.1) MUTATED | 0 | 7 | 35 | 356 |
DEL PEAK 7(3P14.1) WILD-TYPE | 2 | 8 | 81 | 346 |
P value = 0.00116 (logrank test), Q value = 0.0052
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 843 | 211 | 0.1 - 194.8 (30.5) |
DEL PEAK 8(3P12.2) MUTATED | 334 | 109 | 0.1 - 141.7 (36.7) |
DEL PEAK 8(3P12.2) WILD-TYPE | 509 | 102 | 0.1 - 194.8 (27.6) |
P value = 0.0127 (Fisher's exact test), Q value = 0.039
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
DEL PEAK 8(3P12.2) MUTATED | 156 | 42 | 89 | 47 |
DEL PEAK 8(3P12.2) WILD-TYPE | 292 | 61 | 101 | 53 |
P value = 0.00642 (Fisher's exact test), Q value = 0.022
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
DEL PEAK 8(3P12.2) MUTATED | 160 | 51 | 119 | 4 |
DEL PEAK 8(3P12.2) WILD-TYPE | 302 | 72 | 132 | 11 |
P value = 0.0884 (Fisher's exact test), Q value = 0.19
nPatients | FEMALE | MALE |
---|---|---|
ALL | 287 | 572 |
DEL PEAK 8(3P12.2) MUTATED | 100 | 234 |
DEL PEAK 8(3P12.2) WILD-TYPE | 187 | 338 |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
DEL PEAK 8(3P12.2) MUTATED | 11 | 304 | 19 |
DEL PEAK 8(3P12.2) WILD-TYPE | 55 | 220 | 250 |
P value = 0.0826 (Wilcoxon-test), Q value = 0.18
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 67 | 1973.4 (16.4) |
DEL PEAK 8(3P12.2) MUTATED | 11 | 1980.5 (17.8) |
DEL PEAK 8(3P12.2) WILD-TYPE | 56 | 1972.0 (15.9) |
P value = 0.00473 (Fisher's exact test), Q value = 0.017
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 116 | 702 |
DEL PEAK 8(3P12.2) MUTATED | 0 | 6 | 30 | 292 |
DEL PEAK 8(3P12.2) WILD-TYPE | 2 | 9 | 86 | 410 |
P value = 7.22e-09 (logrank test), Q value = 8.8e-07
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 843 | 211 | 0.1 - 194.8 (30.5) |
DEL PEAK 9(4Q34.3) MUTATED | 110 | 50 | 0.1 - 112.8 (22.8) |
DEL PEAK 9(4Q34.3) WILD-TYPE | 733 | 161 | 0.1 - 194.8 (30.6) |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
DEL PEAK 9(4Q34.3) MUTATED | 26 | 10 | 48 | 24 |
DEL PEAK 9(4Q34.3) WILD-TYPE | 422 | 93 | 142 | 76 |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
DEL PEAK 9(4Q34.3) MUTATED | 29 | 14 | 59 | 7 |
DEL PEAK 9(4Q34.3) WILD-TYPE | 433 | 109 | 192 | 8 |
P value = 0.0109 (Fisher's exact test), Q value = 0.035
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 317 | 43 | 6 |
DEL PEAK 9(4Q34.3) MUTATED | 40 | 13 | 0 |
DEL PEAK 9(4Q34.3) WILD-TYPE | 277 | 30 | 6 |
P value = 0.0143 (Fisher's exact test), Q value = 0.043
nPatients | 0 | 1 |
---|---|---|
ALL | 542 | 89 |
DEL PEAK 9(4Q34.3) MUTATED | 71 | 21 |
DEL PEAK 9(4Q34.3) WILD-TYPE | 471 | 68 |
P value = 0.0318 (Fisher's exact test), Q value = 0.084
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
DEL PEAK 9(4Q34.3) MUTATED | 3 | 78 | 30 |
DEL PEAK 9(4Q34.3) WILD-TYPE | 63 | 446 | 239 |
P value = 0.0647 (Fisher's exact test), Q value = 0.15
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 116 | 702 |
DEL PEAK 9(4Q34.3) MUTATED | 0 | 4 | 8 | 93 |
DEL PEAK 9(4Q34.3) WILD-TYPE | 2 | 11 | 108 | 609 |
P value = 0.00445 (Wilcoxon-test), Q value = 0.016
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 853 | 60.1 (12.6) |
DEL PEAK 10(5P15.33) MUTATED | 30 | 52.4 (14.6) |
DEL PEAK 10(5P15.33) WILD-TYPE | 823 | 60.4 (12.4) |
P value = 0.00148 (Fisher's exact test), Q value = 0.0065
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
DEL PEAK 10(5P15.33) MUTATED | 7 | 9 | 9 | 5 |
DEL PEAK 10(5P15.33) WILD-TYPE | 441 | 94 | 181 | 95 |
P value = 0.00057 (Fisher's exact test), Q value = 0.0027
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
DEL PEAK 10(5P15.33) MUTATED | 7 | 11 | 13 | 0 |
DEL PEAK 10(5P15.33) WILD-TYPE | 455 | 112 | 238 | 15 |
P value = 0.00573 (Fisher's exact test), Q value = 0.02
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 317 | 43 | 6 |
DEL PEAK 10(5P15.33) MUTATED | 13 | 5 | 2 |
DEL PEAK 10(5P15.33) WILD-TYPE | 304 | 38 | 4 |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
DEL PEAK 10(5P15.33) MUTATED | 10 | 8 | 13 |
DEL PEAK 10(5P15.33) WILD-TYPE | 56 | 516 | 256 |
P value = 0.124 (Wilcoxon-test), Q value = 0.25
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 853 | 60.1 (12.6) |
DEL PEAK 11(6Q22.31) MUTATED | 223 | 58.6 (13.8) |
DEL PEAK 11(6Q22.31) WILD-TYPE | 630 | 60.6 (12.1) |
P value = 0.00013 (Fisher's exact test), Q value = 0.00076
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
DEL PEAK 11(6Q22.31) MUTATED | 93 | 41 | 55 | 35 |
DEL PEAK 11(6Q22.31) WILD-TYPE | 355 | 62 | 135 | 65 |
P value = 4e-05 (Fisher's exact test), Q value = 0.00028
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
DEL PEAK 11(6Q22.31) MUTATED | 94 | 44 | 80 | 7 |
DEL PEAK 11(6Q22.31) WILD-TYPE | 368 | 79 | 171 | 8 |
P value = 0.0357 (Fisher's exact test), Q value = 0.092
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 317 | 43 | 6 |
DEL PEAK 11(6Q22.31) MUTATED | 87 | 17 | 4 |
DEL PEAK 11(6Q22.31) WILD-TYPE | 230 | 26 | 2 |
P value = 0.107 (Wilcoxon-test), Q value = 0.22
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 115 | 90.3 (17.6) |
DEL PEAK 11(6Q22.31) MUTATED | 32 | 85.6 (24.2) |
DEL PEAK 11(6Q22.31) WILD-TYPE | 83 | 92.0 (14.0) |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
DEL PEAK 11(6Q22.31) MUTATED | 51 | 147 | 27 |
DEL PEAK 11(6Q22.31) WILD-TYPE | 15 | 377 | 242 |
P value = 0.00221 (Fisher's exact test), Q value = 0.0088
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 116 | 702 |
DEL PEAK 11(6Q22.31) MUTATED | 0 | 6 | 16 | 195 |
DEL PEAK 11(6Q22.31) WILD-TYPE | 2 | 9 | 100 | 507 |
P value = 6e-05 (Fisher's exact test), Q value = 0.00038
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
DEL PEAK 12(6Q26) MUTATED | 94 | 43 | 58 | 34 |
DEL PEAK 12(6Q26) WILD-TYPE | 354 | 60 | 132 | 66 |
P value = 5e-05 (Fisher's exact test), Q value = 0.00033
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
DEL PEAK 12(6Q26) MUTATED | 95 | 46 | 83 | 6 |
DEL PEAK 12(6Q26) WILD-TYPE | 367 | 77 | 168 | 9 |
P value = 0.0548 (Fisher's exact test), Q value = 0.13
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 317 | 43 | 6 |
DEL PEAK 12(6Q26) MUTATED | 92 | 17 | 4 |
DEL PEAK 12(6Q26) WILD-TYPE | 225 | 26 | 2 |
P value = 0.086 (Wilcoxon-test), Q value = 0.19
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 115 | 90.3 (17.6) |
DEL PEAK 12(6Q26) MUTATED | 33 | 85.8 (23.9) |
DEL PEAK 12(6Q26) WILD-TYPE | 82 | 92.1 (14.1) |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
DEL PEAK 12(6Q26) MUTATED | 51 | 151 | 28 |
DEL PEAK 12(6Q26) WILD-TYPE | 15 | 373 | 241 |
P value = 0.00126 (Fisher's exact test), Q value = 0.0056
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 116 | 702 |
DEL PEAK 12(6Q26) MUTATED | 0 | 6 | 16 | 200 |
DEL PEAK 12(6Q26) WILD-TYPE | 2 | 9 | 100 | 502 |
P value = 8e-05 (Fisher's exact test), Q value = 5e-04
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
DEL PEAK 13(6Q26) MUTATED | 95 | 43 | 58 | 34 |
DEL PEAK 13(6Q26) WILD-TYPE | 353 | 60 | 132 | 66 |
P value = 6e-05 (Fisher's exact test), Q value = 0.00038
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
DEL PEAK 13(6Q26) MUTATED | 96 | 46 | 83 | 6 |
DEL PEAK 13(6Q26) WILD-TYPE | 366 | 77 | 168 | 9 |
P value = 0.0549 (Fisher's exact test), Q value = 0.13
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 317 | 43 | 6 |
DEL PEAK 13(6Q26) MUTATED | 92 | 17 | 4 |
DEL PEAK 13(6Q26) WILD-TYPE | 225 | 26 | 2 |
P value = 0.086 (Wilcoxon-test), Q value = 0.19
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 115 | 90.3 (17.6) |
DEL PEAK 13(6Q26) MUTATED | 33 | 85.8 (23.9) |
DEL PEAK 13(6Q26) WILD-TYPE | 82 | 92.1 (14.1) |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
DEL PEAK 13(6Q26) MUTATED | 51 | 151 | 29 |
DEL PEAK 13(6Q26) WILD-TYPE | 15 | 373 | 240 |
P value = 0.00323 (Fisher's exact test), Q value = 0.012
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 116 | 702 |
DEL PEAK 13(6Q26) MUTATED | 0 | 6 | 17 | 200 |
DEL PEAK 13(6Q26) WILD-TYPE | 2 | 9 | 99 | 502 |
P value = 0.000909 (logrank test), Q value = 0.0042
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 843 | 211 | 0.1 - 194.8 (30.5) |
DEL PEAK 14(8P23.2) MUTATED | 181 | 63 | 0.1 - 137.1 (31.9) |
DEL PEAK 14(8P23.2) WILD-TYPE | 662 | 148 | 0.1 - 194.8 (30.3) |
P value = 0.00201 (Fisher's exact test), Q value = 0.0083
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
DEL PEAK 14(8P23.2) MUTATED | 75 | 25 | 48 | 32 |
DEL PEAK 14(8P23.2) WILD-TYPE | 373 | 78 | 142 | 68 |
P value = 0.00183 (Fisher's exact test), Q value = 0.0078
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
DEL PEAK 14(8P23.2) MUTATED | 77 | 30 | 68 | 6 |
DEL PEAK 14(8P23.2) WILD-TYPE | 385 | 93 | 183 | 9 |
P value = 0.0257 (Fisher's exact test), Q value = 0.069
nPatients | 0 | 1 |
---|---|---|
ALL | 542 | 89 |
DEL PEAK 14(8P23.2) MUTATED | 131 | 32 |
DEL PEAK 14(8P23.2) WILD-TYPE | 411 | 57 |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
DEL PEAK 14(8P23.2) MUTATED | 12 | 154 | 15 |
DEL PEAK 14(8P23.2) WILD-TYPE | 54 | 370 | 254 |
P value = 0.00376 (Fisher's exact test), Q value = 0.014
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 116 | 702 |
DEL PEAK 14(8P23.2) MUTATED | 0 | 7 | 14 | 157 |
DEL PEAK 14(8P23.2) WILD-TYPE | 2 | 8 | 102 | 545 |
P value = 2.91e-11 (logrank test), Q value = 4.9e-09
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 843 | 211 | 0.1 - 194.8 (30.5) |
DEL PEAK 15(9P23) MUTATED | 193 | 85 | 0.1 - 141.7 (31.3) |
DEL PEAK 15(9P23) WILD-TYPE | 650 | 126 | 0.1 - 194.8 (30.3) |
P value = 0.0247 (Wilcoxon-test), Q value = 0.068
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 853 | 60.1 (12.6) |
DEL PEAK 15(9P23) MUTATED | 194 | 61.8 (12.0) |
DEL PEAK 15(9P23) WILD-TYPE | 659 | 59.6 (12.7) |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
DEL PEAK 15(9P23) MUTATED | 64 | 16 | 69 | 43 |
DEL PEAK 15(9P23) WILD-TYPE | 384 | 87 | 121 | 57 |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
DEL PEAK 15(9P23) MUTATED | 68 | 23 | 96 | 7 |
DEL PEAK 15(9P23) WILD-TYPE | 394 | 100 | 155 | 8 |
P value = 0.00724 (Fisher's exact test), Q value = 0.024
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 317 | 43 | 6 |
DEL PEAK 15(9P23) MUTATED | 71 | 19 | 2 |
DEL PEAK 15(9P23) WILD-TYPE | 246 | 24 | 4 |
P value = 0.000223 (Fisher's exact test), Q value = 0.0012
nPatients | 0 | 1 |
---|---|---|
ALL | 542 | 89 |
DEL PEAK 15(9P23) MUTATED | 126 | 38 |
DEL PEAK 15(9P23) WILD-TYPE | 416 | 51 |
P value = 0.0204 (Wilcoxon-test), Q value = 0.059
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 115 | 90.3 (17.6) |
DEL PEAK 15(9P23) MUTATED | 23 | 83.0 (27.0) |
DEL PEAK 15(9P23) WILD-TYPE | 92 | 92.1 (13.9) |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
DEL PEAK 15(9P23) MUTATED | 10 | 151 | 35 |
DEL PEAK 15(9P23) WILD-TYPE | 56 | 373 | 234 |
P value = 0.0126 (Fisher's exact test), Q value = 0.039
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 116 | 702 |
DEL PEAK 15(9P23) MUTATED | 0 | 4 | 14 | 172 |
DEL PEAK 15(9P23) WILD-TYPE | 2 | 11 | 102 | 530 |
P value = 1.12e-14 (logrank test), Q value = 5.7e-12
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 843 | 211 | 0.1 - 194.8 (30.5) |
DEL PEAK 16(9P21.3) MUTATED | 203 | 93 | 0.1 - 141.7 (28.9) |
DEL PEAK 16(9P21.3) WILD-TYPE | 640 | 118 | 0.1 - 194.8 (30.7) |
P value = 0.0358 (Wilcoxon-test), Q value = 0.092
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 853 | 60.1 (12.6) |
DEL PEAK 16(9P21.3) MUTATED | 205 | 61.6 (12.2) |
DEL PEAK 16(9P21.3) WILD-TYPE | 648 | 59.6 (12.7) |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
DEL PEAK 16(9P21.3) MUTATED | 66 | 15 | 74 | 48 |
DEL PEAK 16(9P21.3) WILD-TYPE | 382 | 88 | 116 | 52 |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
DEL PEAK 16(9P21.3) MUTATED | 70 | 22 | 105 | 8 |
DEL PEAK 16(9P21.3) WILD-TYPE | 392 | 101 | 146 | 7 |
P value = 0.00013 (Fisher's exact test), Q value = 0.00076
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 317 | 43 | 6 |
DEL PEAK 16(9P21.3) MUTATED | 77 | 24 | 2 |
DEL PEAK 16(9P21.3) WILD-TYPE | 240 | 19 | 4 |
P value = 9.23e-06 (Fisher's exact test), Q value = 7.6e-05
nPatients | 0 | 1 |
---|---|---|
ALL | 542 | 89 |
DEL PEAK 16(9P21.3) MUTATED | 131 | 43 |
DEL PEAK 16(9P21.3) WILD-TYPE | 411 | 46 |
P value = 0.0401 (Wilcoxon-test), Q value = 0.1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 115 | 90.3 (17.6) |
DEL PEAK 16(9P21.3) MUTATED | 24 | 83.8 (26.7) |
DEL PEAK 16(9P21.3) WILD-TYPE | 91 | 92.0 (14.0) |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
DEL PEAK 16(9P21.3) MUTATED | 10 | 159 | 38 |
DEL PEAK 16(9P21.3) WILD-TYPE | 56 | 365 | 231 |
P value = 0.00827 (Fisher's exact test), Q value = 0.027
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 116 | 702 |
DEL PEAK 16(9P21.3) MUTATED | 0 | 3 | 15 | 184 |
DEL PEAK 16(9P21.3) WILD-TYPE | 2 | 12 | 101 | 518 |
P value = 0.0425 (Wilcoxon-test), Q value = 0.11
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 853 | 60.1 (12.6) |
DEL PEAK 17(10Q23.31) MUTATED | 160 | 58.0 (14.0) |
DEL PEAK 17(10Q23.31) WILD-TYPE | 693 | 60.6 (12.2) |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
DEL PEAK 17(10Q23.31) MUTATED | 52 | 32 | 53 | 25 |
DEL PEAK 17(10Q23.31) WILD-TYPE | 396 | 71 | 137 | 75 |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
DEL PEAK 17(10Q23.31) MUTATED | 53 | 33 | 69 | 7 |
DEL PEAK 17(10Q23.31) WILD-TYPE | 409 | 90 | 182 | 8 |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
DEL PEAK 17(10Q23.31) MUTATED | 49 | 96 | 17 |
DEL PEAK 17(10Q23.31) WILD-TYPE | 17 | 428 | 252 |
P value = 0.0994 (Fisher's exact test), Q value = 0.21
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 116 | 702 |
DEL PEAK 17(10Q23.31) MUTATED | 0 | 4 | 13 | 139 |
DEL PEAK 17(10Q23.31) WILD-TYPE | 2 | 11 | 103 | 563 |
P value = 0.00196 (logrank test), Q value = 0.0082
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 843 | 211 | 0.1 - 194.8 (30.5) |
DEL PEAK 18(11Q21) MUTATED | 59 | 22 | 0.1 - 123.6 (19.7) |
DEL PEAK 18(11Q21) WILD-TYPE | 784 | 189 | 0.1 - 194.8 (31.1) |
P value = 0.00478 (Wilcoxon-test), Q value = 0.017
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 853 | 60.1 (12.6) |
DEL PEAK 18(11Q21) MUTATED | 59 | 64.2 (11.0) |
DEL PEAK 18(11Q21) WILD-TYPE | 794 | 59.8 (12.6) |
P value = 0.00026 (Fisher's exact test), Q value = 0.0014
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
DEL PEAK 18(11Q21) MUTATED | 16 | 11 | 20 | 12 |
DEL PEAK 18(11Q21) WILD-TYPE | 432 | 92 | 170 | 88 |
P value = 0.00041 (Fisher's exact test), Q value = 0.0021
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
DEL PEAK 18(11Q21) MUTATED | 17 | 12 | 29 | 1 |
DEL PEAK 18(11Q21) WILD-TYPE | 445 | 111 | 222 | 14 |
P value = 0.00019 (Fisher's exact test), Q value = 0.0011
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 317 | 43 | 6 |
DEL PEAK 18(11Q21) MUTATED | 21 | 11 | 2 |
DEL PEAK 18(11Q21) WILD-TYPE | 296 | 32 | 4 |
P value = 0.0998 (Fisher's exact test), Q value = 0.21
nPatients | 0 | 1 |
---|---|---|
ALL | 542 | 89 |
DEL PEAK 18(11Q21) MUTATED | 30 | 9 |
DEL PEAK 18(11Q21) WILD-TYPE | 512 | 80 |
P value = 0.0624 (Wilcoxon-test), Q value = 0.15
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 115 | 90.3 (17.6) |
DEL PEAK 18(11Q21) MUTATED | 11 | 89.1 (7.0) |
DEL PEAK 18(11Q21) WILD-TYPE | 104 | 90.4 (18.4) |
P value = 0.00304 (Fisher's exact test), Q value = 0.011
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
DEL PEAK 18(11Q21) MUTATED | 9 | 25 | 26 |
DEL PEAK 18(11Q21) WILD-TYPE | 57 | 499 | 243 |
P value = 0.00373 (logrank test), Q value = 0.014
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 843 | 211 | 0.1 - 194.8 (30.5) |
DEL PEAK 19(11Q23.1) MUTATED | 68 | 25 | 0.1 - 123.6 (20.6) |
DEL PEAK 19(11Q23.1) WILD-TYPE | 775 | 186 | 0.1 - 194.8 (30.7) |
P value = 0.00293 (Wilcoxon-test), Q value = 0.011
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 853 | 60.1 (12.6) |
DEL PEAK 19(11Q23.1) MUTATED | 69 | 64.1 (11.0) |
DEL PEAK 19(11Q23.1) WILD-TYPE | 784 | 59.8 (12.6) |
P value = 3e-05 (Fisher's exact test), Q value = 0.00021
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
DEL PEAK 19(11Q23.1) MUTATED | 18 | 13 | 24 | 14 |
DEL PEAK 19(11Q23.1) WILD-TYPE | 430 | 90 | 166 | 86 |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
DEL PEAK 19(11Q23.1) MUTATED | 19 | 15 | 32 | 3 |
DEL PEAK 19(11Q23.1) WILD-TYPE | 443 | 108 | 219 | 12 |
P value = 0.00047 (Fisher's exact test), Q value = 0.0023
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 317 | 43 | 6 |
DEL PEAK 19(11Q23.1) MUTATED | 24 | 11 | 2 |
DEL PEAK 19(11Q23.1) WILD-TYPE | 293 | 32 | 4 |
P value = 0.112 (Fisher's exact test), Q value = 0.23
nPatients | 0 | 1 |
---|---|---|
ALL | 542 | 89 |
DEL PEAK 19(11Q23.1) MUTATED | 34 | 10 |
DEL PEAK 19(11Q23.1) WILD-TYPE | 508 | 79 |
P value = 0.0253 (Wilcoxon-test), Q value = 0.069
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 115 | 90.3 (17.6) |
DEL PEAK 19(11Q23.1) MUTATED | 12 | 88.3 (7.2) |
DEL PEAK 19(11Q23.1) WILD-TYPE | 103 | 90.5 (18.4) |
P value = 0.00361 (Fisher's exact test), Q value = 0.013
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
DEL PEAK 19(11Q23.1) MUTATED | 9 | 30 | 31 |
DEL PEAK 19(11Q23.1) WILD-TYPE | 57 | 494 | 238 |
P value = 0.0323 (logrank test), Q value = 0.085
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 843 | 211 | 0.1 - 194.8 (30.5) |
DEL PEAK 20(13Q12.13) MUTATED | 146 | 53 | 0.1 - 152.0 (36.7) |
DEL PEAK 20(13Q12.13) WILD-TYPE | 697 | 158 | 0.1 - 194.8 (29.5) |
P value = 0.000423 (Wilcoxon-test), Q value = 0.0021
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 853 | 60.1 (12.6) |
DEL PEAK 20(13Q12.13) MUTATED | 148 | 56.2 (15.2) |
DEL PEAK 20(13Q12.13) WILD-TYPE | 705 | 60.9 (11.8) |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
DEL PEAK 20(13Q12.13) MUTATED | 46 | 24 | 50 | 28 |
DEL PEAK 20(13Q12.13) WILD-TYPE | 402 | 79 | 140 | 72 |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
DEL PEAK 20(13Q12.13) MUTATED | 48 | 26 | 65 | 9 |
DEL PEAK 20(13Q12.13) WILD-TYPE | 414 | 97 | 186 | 6 |
P value = 0.0135 (Fisher's exact test), Q value = 0.041
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 317 | 43 | 6 |
DEL PEAK 20(13Q12.13) MUTATED | 68 | 14 | 4 |
DEL PEAK 20(13Q12.13) WILD-TYPE | 249 | 29 | 2 |
P value = 0.0212 (Fisher's exact test), Q value = 0.06
nPatients | FEMALE | MALE |
---|---|---|
ALL | 287 | 572 |
DEL PEAK 20(13Q12.13) MUTATED | 62 | 86 |
DEL PEAK 20(13Q12.13) WILD-TYPE | 225 | 486 |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
DEL PEAK 20(13Q12.13) MUTATED | 44 | 81 | 23 |
DEL PEAK 20(13Q12.13) WILD-TYPE | 22 | 443 | 246 |
P value = 0.103 (Fisher's exact test), Q value = 0.21
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 116 | 702 |
DEL PEAK 20(13Q12.13) MUTATED | 0 | 4 | 12 | 127 |
DEL PEAK 20(13Q12.13) WILD-TYPE | 2 | 11 | 104 | 575 |
P value = 0.0241 (logrank test), Q value = 0.067
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 843 | 211 | 0.1 - 194.8 (30.5) |
DEL PEAK 21(13Q14.2) MUTATED | 146 | 53 | 0.1 - 152.0 (33.7) |
DEL PEAK 21(13Q14.2) WILD-TYPE | 697 | 158 | 0.1 - 194.8 (29.9) |
P value = 8.11e-05 (Wilcoxon-test), Q value = 5e-04
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 853 | 60.1 (12.6) |
DEL PEAK 21(13Q14.2) MUTATED | 148 | 55.7 (15.0) |
DEL PEAK 21(13Q14.2) WILD-TYPE | 705 | 61.0 (11.8) |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
DEL PEAK 21(13Q14.2) MUTATED | 46 | 22 | 51 | 29 |
DEL PEAK 21(13Q14.2) WILD-TYPE | 402 | 81 | 139 | 71 |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
DEL PEAK 21(13Q14.2) MUTATED | 48 | 24 | 67 | 9 |
DEL PEAK 21(13Q14.2) WILD-TYPE | 414 | 99 | 184 | 6 |
P value = 0.015 (Fisher's exact test), Q value = 0.045
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 317 | 43 | 6 |
DEL PEAK 21(13Q14.2) MUTATED | 69 | 14 | 4 |
DEL PEAK 21(13Q14.2) WILD-TYPE | 248 | 29 | 2 |
P value = 0.0125 (Fisher's exact test), Q value = 0.039
nPatients | FEMALE | MALE |
---|---|---|
ALL | 287 | 572 |
DEL PEAK 21(13Q14.2) MUTATED | 63 | 85 |
DEL PEAK 21(13Q14.2) WILD-TYPE | 224 | 487 |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
DEL PEAK 21(13Q14.2) MUTATED | 43 | 82 | 23 |
DEL PEAK 21(13Q14.2) WILD-TYPE | 23 | 442 | 246 |
P value = 0.104 (Fisher's exact test), Q value = 0.21
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 116 | 702 |
DEL PEAK 21(13Q14.2) MUTATED | 0 | 4 | 12 | 127 |
DEL PEAK 21(13Q14.2) WILD-TYPE | 2 | 11 | 104 | 575 |
P value = 8.67e-09 (logrank test), Q value = 8.8e-07
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 843 | 211 | 0.1 - 194.8 (30.5) |
DEL PEAK 22(14Q31.1) MUTATED | 273 | 103 | 0.1 - 129.4 (30.5) |
DEL PEAK 22(14Q31.1) WILD-TYPE | 570 | 108 | 0.1 - 194.8 (30.5) |
P value = 0.0799 (Wilcoxon-test), Q value = 0.18
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 853 | 60.1 (12.6) |
DEL PEAK 22(14Q31.1) MUTATED | 273 | 61.3 (12.4) |
DEL PEAK 22(14Q31.1) WILD-TYPE | 580 | 59.6 (12.6) |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
DEL PEAK 22(14Q31.1) MUTATED | 103 | 31 | 83 | 54 |
DEL PEAK 22(14Q31.1) WILD-TYPE | 345 | 72 | 107 | 46 |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
DEL PEAK 22(14Q31.1) MUTATED | 110 | 40 | 119 | 5 |
DEL PEAK 22(14Q31.1) WILD-TYPE | 352 | 83 | 132 | 10 |
P value = 0.00205 (Fisher's exact test), Q value = 0.0083
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 317 | 43 | 6 |
DEL PEAK 22(14Q31.1) MUTATED | 108 | 26 | 3 |
DEL PEAK 22(14Q31.1) WILD-TYPE | 209 | 17 | 3 |
P value = 4.84e-05 (Fisher's exact test), Q value = 0.00033
nPatients | 0 | 1 |
---|---|---|
ALL | 542 | 89 |
DEL PEAK 22(14Q31.1) MUTATED | 185 | 51 |
DEL PEAK 22(14Q31.1) WILD-TYPE | 357 | 38 |
P value = 0.0447 (Wilcoxon-test), Q value = 0.11
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 115 | 90.3 (17.6) |
DEL PEAK 22(14Q31.1) MUTATED | 30 | 82.0 (29.3) |
DEL PEAK 22(14Q31.1) WILD-TYPE | 85 | 93.2 (9.5) |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
DEL PEAK 22(14Q31.1) MUTATED | 3 | 226 | 45 |
DEL PEAK 22(14Q31.1) WILD-TYPE | 63 | 298 | 224 |
P value = 0.00272 (Wilcoxon-test), Q value = 0.011
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 67 | 1973.4 (16.4) |
DEL PEAK 22(14Q31.1) MUTATED | 11 | 1987.4 (14.2) |
DEL PEAK 22(14Q31.1) WILD-TYPE | 56 | 1970.7 (15.5) |
P value = 0.011 (Fisher's exact test), Q value = 0.035
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 116 | 702 |
DEL PEAK 22(14Q31.1) MUTATED | 0 | 3 | 24 | 240 |
DEL PEAK 22(14Q31.1) WILD-TYPE | 2 | 12 | 92 | 462 |
P value = 9.39e-06 (logrank test), Q value = 7.6e-05
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 843 | 211 | 0.1 - 194.8 (30.5) |
DEL PEAK 23(16Q23.3) MUTATED | 35 | 18 | 0.1 - 90.5 (27.6) |
DEL PEAK 23(16Q23.3) WILD-TYPE | 808 | 193 | 0.1 - 194.8 (30.6) |
P value = 0.00647 (Fisher's exact test), Q value = 0.022
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
DEL PEAK 23(16Q23.3) MUTATED | 11 | 4 | 11 | 10 |
DEL PEAK 23(16Q23.3) WILD-TYPE | 437 | 99 | 179 | 90 |
P value = 0.00014 (Fisher's exact test), Q value = 0.00081
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
DEL PEAK 23(16Q23.3) MUTATED | 12 | 4 | 15 | 5 |
DEL PEAK 23(16Q23.3) WILD-TYPE | 450 | 119 | 236 | 10 |
P value = 0.00046 (Fisher's exact test), Q value = 0.0023
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 317 | 43 | 6 |
DEL PEAK 23(16Q23.3) MUTATED | 12 | 7 | 2 |
DEL PEAK 23(16Q23.3) WILD-TYPE | 305 | 36 | 4 |
P value = 6.48e-07 (logrank test), Q value = 5.5e-05
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 843 | 211 | 0.1 - 194.8 (30.5) |
DEL PEAK 24(18Q22.2) MUTATED | 149 | 59 | 0.1 - 123.6 (25.6) |
DEL PEAK 24(18Q22.2) WILD-TYPE | 694 | 152 | 0.1 - 194.8 (31.3) |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
DEL PEAK 24(18Q22.2) MUTATED | 51 | 12 | 55 | 31 |
DEL PEAK 24(18Q22.2) WILD-TYPE | 397 | 91 | 135 | 69 |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
DEL PEAK 24(18Q22.2) MUTATED | 54 | 17 | 73 | 7 |
DEL PEAK 24(18Q22.2) WILD-TYPE | 408 | 106 | 178 | 8 |
P value = 0.0213 (Fisher's exact test), Q value = 0.06
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 317 | 43 | 6 |
DEL PEAK 24(18Q22.2) MUTATED | 64 | 15 | 3 |
DEL PEAK 24(18Q22.2) WILD-TYPE | 253 | 28 | 3 |
P value = 0.00917 (Fisher's exact test), Q value = 0.029
nPatients | 0 | 1 |
---|---|---|
ALL | 542 | 89 |
DEL PEAK 24(18Q22.2) MUTATED | 97 | 27 |
DEL PEAK 24(18Q22.2) WILD-TYPE | 445 | 62 |
P value = 0.117 (Wilcoxon-test), Q value = 0.24
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 67 | 1973.4 (16.4) |
DEL PEAK 24(18Q22.2) MUTATED | 8 | 1981.1 (13.2) |
DEL PEAK 24(18Q22.2) WILD-TYPE | 59 | 1972.4 (16.6) |
P value = 0.0746 (Fisher's exact test), Q value = 0.17
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | WHITE |
---|---|---|---|---|
ALL | 2 | 15 | 116 | 702 |
DEL PEAK 24(18Q22.2) MUTATED | 0 | 6 | 15 | 128 |
DEL PEAK 24(18Q22.2) WILD-TYPE | 2 | 9 | 101 | 574 |
P value = 0.0894 (Fisher's exact test), Q value = 0.19
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 42 | 597 |
DEL PEAK 24(18Q22.2) MUTATED | 3 | 106 |
DEL PEAK 24(18Q22.2) WILD-TYPE | 39 | 491 |
P value = 8.5e-12 (logrank test), Q value = 2.2e-09
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 843 | 211 | 0.1 - 194.8 (30.5) |
DEL PEAK 25(19P13.3) MUTATED | 40 | 21 | 0.1 - 109.9 (17.5) |
DEL PEAK 25(19P13.3) WILD-TYPE | 803 | 190 | 0.1 - 194.8 (31.3) |
P value = 6e-05 (Fisher's exact test), Q value = 0.00038
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
DEL PEAK 25(19P13.3) MUTATED | 10 | 1 | 17 | 11 |
DEL PEAK 25(19P13.3) WILD-TYPE | 438 | 102 | 173 | 89 |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
DEL PEAK 25(19P13.3) MUTATED | 11 | 2 | 23 | 4 |
DEL PEAK 25(19P13.3) WILD-TYPE | 451 | 121 | 228 | 11 |
P value = 0.00022 (Fisher's exact test), Q value = 0.0012
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 317 | 43 | 6 |
DEL PEAK 25(19P13.3) MUTATED | 10 | 7 | 2 |
DEL PEAK 25(19P13.3) WILD-TYPE | 307 | 36 | 4 |
P value = 0.064 (Fisher's exact test), Q value = 0.15
nPatients | 0 | 1 |
---|---|---|
ALL | 542 | 89 |
DEL PEAK 25(19P13.3) MUTATED | 17 | 7 |
DEL PEAK 25(19P13.3) WILD-TYPE | 525 | 82 |
P value = 0.0779 (Wilcoxon-test), Q value = 0.17
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 115 | 90.3 (17.6) |
DEL PEAK 25(19P13.3) MUTATED | 9 | 80.0 (30.8) |
DEL PEAK 25(19P13.3) WILD-TYPE | 106 | 91.1 (15.9) |
P value = 0.0287 (Fisher's exact test), Q value = 0.076
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
DEL PEAK 25(19P13.3) MUTATED | 3 | 17 | 20 |
DEL PEAK 25(19P13.3) WILD-TYPE | 63 | 507 | 249 |
P value = 0.00136 (Wilcoxon-test), Q value = 0.006
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 853 | 60.1 (12.6) |
DEL PEAK 26(XP22.2) MUTATED | 123 | 56.2 (13.9) |
DEL PEAK 26(XP22.2) WILD-TYPE | 730 | 60.8 (12.2) |
P value = 1e-04 (Fisher's exact test), Q value = 0.00061
nPatients | STAGE I | STAGE II | STAGE III | STAGE IV |
---|---|---|---|---|
ALL | 448 | 103 | 190 | 100 |
DEL PEAK 26(XP22.2) MUTATED | 43 | 24 | 39 | 14 |
DEL PEAK 26(XP22.2) WILD-TYPE | 405 | 79 | 151 | 86 |
P value = 0.00025 (Fisher's exact test), Q value = 0.0013
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 462 | 123 | 251 | 15 |
DEL PEAK 26(XP22.2) MUTATED | 44 | 26 | 49 | 3 |
DEL PEAK 26(XP22.2) WILD-TYPE | 418 | 97 | 202 | 12 |
P value = 0.0948 (Fisher's exact test), Q value = 0.2
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 317 | 43 | 6 |
DEL PEAK 26(XP22.2) MUTATED | 48 | 11 | 2 |
DEL PEAK 26(XP22.2) WILD-TYPE | 269 | 32 | 4 |
P value = 1e-05 (Fisher's exact test), Q value = 7.6e-05
nPatients | KIDNEY CHROMOPHOBE | KIDNEY CLEAR CELL RENAL CARCINOMA | KIDNEY PAPILLARY RENAL CELL CARCINOMA |
---|---|---|---|
ALL | 66 | 524 | 269 |
DEL PEAK 26(XP22.2) MUTATED | 39 | 55 | 29 |
DEL PEAK 26(XP22.2) WILD-TYPE | 27 | 469 | 240 |
-
Copy number data file = all_lesions.txt from GISTIC pipeline
-
Processed Copy number data file = /xchip/cga/gdac-prod/tcga-gdac/jobResults/GDAC_Correlate_Genomic_Events_Preprocess/KIPAN-TP/15087107/transformed.cor.cli.txt
-
Clinical data file = /xchip/cga/gdac-prod/tcga-gdac/jobResults/Append_Data/KIPAN-TP/15081103/KIPAN-TP.merged_data.txt
-
Number of patients = 859
-
Number of significantly focal cnvs = 39
-
Number of selected clinical features = 13
-
Exclude genes that fewer than K tumors have mutations, K = 3
For survival clinical features, the Kaplan-Meier survival curves of tumors with and without gene mutations were plotted and the statistical significance P values were estimated by logrank test (Bland and Altman 2004) using the 'survdiff' function in R
For binary or multi-class clinical features (nominal or ordinal), two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.
In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.